|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| HTLV-I | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dermatitis | |||||
| Paraparesis | |||||
| Paraparesis, Spastic | |||||
| Paraparesis, Tropical Spastic | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| Central Nervous System Infections | |||||
| Central Nervous System Viral Diseases | |||||
| Deltaretrovirus Infections | |||||
| HTLV-I Infections | |||||
| Myelitis | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Paresis | |||||
| Retroviridae Infections | |||||
| RNA Virus Infections | |||||
| Signs and Symptoms | |||||
| Skin Diseases | |||||
| Spinal Cord Diseases | |||||
| Virus Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Cancer Institute (NCI) | |||||